Literature DB >> 17175066

A case of Churg-Strauss syndrome associated with antiphospholipid antibodies.

Katalin Ferenczi1, Timothy Chang, Melissa Camouse, Rujing Han, Robert Stern, Joseph Willis, Kevin D Cooper, Anita C Gilliam.   

Abstract

Churg-Strauss syndrome (CSS) is a systemic vasculitis affecting both small- and medium-sized blood vessels, almost invariably affecting the lung, and frequently associated with cutaneous involvement. Microvascular vaso-occlusion leading to digital gangrene is not a feature of CSS. We report an unusual case of a patient with CSS with antiphospholipid antibodies who developed severe digital gangrene in addition to cutaneous vasculitis. The presence of antiphospholipid antibodies is not a feature usually seen in association with CSS. While the full clinical spectrum of CSS is still being defined, the identification of additional features associated with this syndrome might help to better understand the pathogenesis of the disease and to have an impact on both management and prognosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17175066      PMCID: PMC2573873          DOI: 10.1016/j.jaad.2006.09.028

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  18 in total

1.  Churg-Strauss syndrome or other disease?

Authors:  A E Acciarini; S Rubino; L Biscarini; Favero A Del
Journal:  Clin Exp Rheumatol       Date:  2002 Jan-Feb       Impact factor: 4.473

2.  Gangrene of the feet in Churg-Strauss syndrome.

Authors:  Jochanan E Naschitz; Zeev Loberman; Vladimir Wolffson; Jay P Babich; Daniel Yeshurun
Journal:  Vasc Med       Date:  2003-05       Impact factor: 3.239

3.  Prevalence of the antiphospholipid syndrome in primary systemic vasculitis.

Authors:  J D Rees; S Lança; P V Marques; J A Gómez-Puerta; R Moco; C Oliveri; M A Khamashta; G R V Hughes; D P D'Cruz
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

Review 4.  Recent advances in the diagnosis of Churg-Strauss syndrome.

Authors:  A Churg
Journal:  Mod Pathol       Date:  2001-12       Impact factor: 7.842

5.  The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.

Authors:  P A Merkel; Y Chang; S S Pierangeli; K Convery; E N Harris; R P Polisson
Journal:  Am J Med       Date:  1996-12       Impact factor: 4.965

Review 6.  Churg-Strauss syndrome.

Authors:  Imre Noth; Mary E Strek; Alan R Leff
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

7.  Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients.

Authors:  L Guillevin; P Cohen; M Gayraud; F Lhote; B Jarrousse; P Casassus
Journal:  Medicine (Baltimore)       Date:  1999-01       Impact factor: 1.889

Review 8.  Recent advances in the management of asthma using leukotriene modifiers.

Authors:  James P Kemp
Journal:  Am J Respir Med       Date:  2003

9.  Vasculitis induced by zafirlukast therapy.

Authors:  M Soy; H Ozer; A Canataroglu; D Gumurdulu; E Erken
Journal:  Clin Rheumatol       Date:  2002-08       Impact factor: 2.980

Review 10.  The Churg Strauss syndrome (allergic granulomatous angiitis): review and update.

Authors:  Andy Abril; Kenneth T Calamia; Marc D Cohen
Journal:  Semin Arthritis Rheum       Date:  2003-10       Impact factor: 5.532

View more
  3 in total

Review 1.  Cutaneous manifestations of Churg-Strauss syndrome: report of two cases and review of the literature.

Authors:  Laura Bosco; Anna Peroni; Donatella Schena; Chiara Colato; Giampiero Girolomoni
Journal:  Clin Rheumatol       Date:  2010-10-15       Impact factor: 2.980

2.  Churg-Strauss syndrome associated with antiphospholipid antibodies in a patient with recurrent myocardial and cerebral ischemia.

Authors:  Marino Paroli; Alessandro Polidoro; Simone Romano; Daniele Accapezzato
Journal:  Int Med Case Rep J       Date:  2012-11-01

3.  Antineutrophil cytoplasmic antibody-associated vasculitis in presence of positive antiphospholipid antibody: a case report.

Authors:  Maassoumeh Akhlaghi Kalahroodi; Maryam Loghman; Mahsa Ramezanpoor; Reza Shahriarirad; Ehsan Rahmanian
Journal:  J Med Case Rep       Date:  2022-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.